PROSTATE
Primary Tumor (pT)
___ Not identified
___ pT2:
+ ___ pT2a:
+ ___ pT2b:
+ ___ pT2c:
pT3:
___ pT3a:
___ pT3b:
___ pT4:
Regional Lymph Nodes (pN)
___ pNX:
___ pN0:
___ pN1:
Distant Metastasis (pM)
___ Not applicable
___ pM1:
___ pM1a:
___ pM1b:
___ pM1c:
PROSTATE
Primary Tumor (pT)
___ Not identified
___ pT2: Organ confined
+ ___ pT2a: Unilateral, involving one-half of 1 side or less
+ ___ pT2b: Unilateral, involving more than one-half of 1 side but not both sides
+ ___ pT2c: Bilateral disease
pT3: Extraprostatic extension
___ pT3a: Extraprostatic extension or microscopic invasion of bladder neck
___ pT3b: Seminal vesicle invasion
___ pT4: Invasion of rectum, levator muscles and/or pelvic wall (Note J)
Note: There is no pathologic T1 classification. Subdivision of pT2 disease is problematic and has not proven to be of prognostic significance.
Regional Lymph Nodes (pN)
___ pNX: Cannot be assessed
___ pN0: No regional lymph node metastasis
___ pN1: Metastasis in regional lymph node or nodes
Distant Metastasis (pM)
___ Not applicable
___ pM1: Distant metastasis
___ pM1a: Nonregional lymph nodes(s)
___ pM1b: Bone(s)
___ pM1c: Other site(s) with or without bone disease
Note: When more than 1 site of metastasis is present, the most advanced category is used. pM1c is most advanced.
Prostate Staging

Prostate Staging

BLADDER
Primary Tumor (pT)
___ pTX:
___ pT0:
___ pTa:
___ pTis:
___ pT1:
pT2:
___ pT2a:
___ pT2b:
pT3:
___ pT3a:
___ pT3b:
pT4:
___ pT4a:
___ pT4b:
Regional Lymph Nodes (pN)
___ pNX:
___ pN0:
___ pN1:
___ pN2:
___ pN3:
Distant Metastasis (pM)
___ Not applicable
___ pM1:
BLADDER
Primary Tumor (pT)
___ pTX: Primary tumor cannot be assessed
___ pT0: No evidence of primary tumor
___ pTa: Noninvasive papillary carcinoma
___ pTis: Carcinoma in situ: “flat tumor”
___ pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT2: Tumor invades muscularis propria (detrusor muscle)
___ pT2a: Tumor invades superficial muscularis propria (inner half)
___ pT2b: Tumor invades deep muscularis propria (outer half)
pT3: Tumor invades perivesical tissue
___ pT3a: Microscopically
___ pT3b: Macroscopically (extravesicular mass)
pT4: Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall
___ pT4a: Tumor invades prostatic stroma or uterus or vagina
___ pT4b: Tumor invades pelvic wall or abdominal wall
Regional Lymph Nodes (pN)
___ pNX: Lymph nodes cannot be assessed
___ pN0: No lymph node metastasis
___ pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node)
___ pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obrutrator, external iliac or presacral lymph node metastasis)
___ pN3: Lymph node metastasis to the common iliac lymph nodes
Distant Metastasis (pM)
___ Not applicable
___ pM1: Distant metastasis


Bladder Staging

Bladder Staging

Histologic Grade (Fuhrman Nuclear Grade)
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM)
Histologic Grade (Fuhrman Nuclear Grade)
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM)


Kidney Staging

Kidney Staging

Breast
Primary Tumor (Invasive Carcinoma) (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Primary Tumor (Invasive Carcinoma) (pT)
Regional Lymph Nodes (pN)
Nodes containing only ITCs are excluded from the total positive node count for purposes of N classification but should be included in the total number of nodes evaluated.
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Breast Staging

Breast Staging

Cervix
Cervix
Histologic Grade
Primary Tumor (pT)
Regional Lymph Nodes (pN) (select all that apply)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Cervix
Histologic Grade
Primary Tumor (pT)
Regional Lymph Nodes (pN) (select all that apply)
+ Number of lymph nodes with isolated tumor cells (<0.2 mm):
+ Number of lymph nodes with micrometastasis (>0.2 mm to 2 mm):
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Cervix
FIGO Stage
Cervix
FIGO Stage
Note: The depth of invasion should not be more than 5 mm taken from the base of the epithelium, either surface or glandular, from which it originates. Vascular space invasion should not alter the staging.
Colon
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Colon
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Colon

Colon

Colon T4
Colon T4

Colon Staging

Colon Staging

Endometrium
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Endometrium
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Endometrium
FIGO Stage
Endometrium
FIGO Stage
Endometrium TNM Staging

Endometrium TNM Staging

Esophagus
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Esophagus
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Esophagus

Esophagus

Esophagus Staging - Squamous Cell Carcinoma

Esophagus Staging - Squamous Cell Carcinoma

Esophagus Staging - Adenocarcinoma

Esophagus Staging -

Lung
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
Lung
Primary Tumor (pT)
Regional Lymph Nodes (pN)
Distant Metastasis (pM) (required only if confirmed pathologically in this case)